Wilson Loops and Minimal Surfaces

The AdS/CFT correspondence suggests that the Wilson loop of the large N gauge theory with N=4 supersymmetry in 4 dimensions is described by a minimal surface in AdS_5 x S^5. We examine various aspects of this proposal, comparing gauge theory expectations with computations of minimal surfaces. There is a distinguished class of loops, which we call BPS loops, whose expectation values are free from ultra-violet divergence. We formulate the loop equation for such loops. To the extent that we have checked, the minimal surface in AdS_5 x S^5 gives a solution of the equation. We also discuss the zig-zag symmetry of the loop operator. In the N=4 gauge theory, we expect the zig-zag symmetry to hold when the loop does not couple the scalar fields in the supermultiplet. We will show how this is realized for the minimal surface.Comment: 51 pages, 7 figure

AdS/CFT and the Information Paradox

The information paradox in the quantum evolution of black holes is studied within the framework of the AdS/CFT correspondence. The unitarity of the CFT strongly suggests that all information about an initial state that forms a black hole is returned in the Hawking radiation. The CFT dynamics implies an information retention time of order the black hole lifetime. This fact determines many qualitative properties of the non-local effects that must show up in a semi-classical effective theory in the bulk. We argue that no violations of causality are apparent to local observers, but the semi-classical theory in the bulk duplicates degrees of freedom inside and outside the event horizon. Non-local quantum effects are required to eliminate this redundancy. This leads to a breakdown of the usual classical-quantum correspondence principle in Lorentzian black hole spacetimes.Comment: 16 pages, harvmac, reference added, minor correction

Holography and the Polyakov action

In two dimensional conformal field theory the generating functional for correlators of the stress-energy tensor is given by the non-local Polyakov action associated with the background geometry. We study this functional holographically by calculating the regularized on-shell action of asymptotically AdS gravity in three dimensions, associated with a specified (but arbitrary) boundary metric. This procedure is simplified by making use of the Chern-Simons formulation, and a corresponding first-order expansion of the bulk dreibein, rather than the metric expansion of Fefferman and Graham. The dependence of the resulting functional on local moduli of the boundary metric agrees precisely with the Polyakov action, in accord with the AdS/CFT correspondence. We also verify the consistency of this result with regard to the nontrivial transformation properties of bulk solutions under Brown-Henneaux diffeomorphisms.Comment: 20 pages, RevTeX, v2: minor typos corrected and references adde

Dialectics and difference: against Harvey's dialectical post-Marxism

David Harvey`s recent book, Justice, nature and the geography of difference (JNGD), engages with a central philosophical debate that continues to dominate human geography: the tension between the radical Marxist project of recent decades and the apparently disempowering relativism and `play of difference' of postmodern thought. In this book, Harvey continues to argue for a revised `post-Marxist' approach in human geography which remains based on Hegelian-Marxian principles of dialectical thought. This article develops a critique of that stance, drawing on the work of Jacques Derrida, Gilles Deleuze and Felix Guattari. I argue that dialectical thinking, as well as Harvey's version of `post-Marxism', has been undermined by the wide-ranging `post-' critique. I suggest that Harvey has failed to appreciate the full force of this critique and the implications it has for `post-Marxist' ontology and epistemology. I argue that `post-Marxism', along with much contemporary human geography, is constrained by an inflexible ontology which excessively prioritizes space in the theory produced, and which implements inflexible concepts. Instead, using the insights of several `post-' writers, I contend there is a need to develop an ontology of `context' leading to the production of `contextual theories'. Such theories utilize flexible concepts in a multilayered understanding of ontology and epistemology. I compare how an approach which produces a `contextual theory' might lead to more politically empowering theory than `post-Marxism' with reference to one of Harvey's case studies in JNGD

Miniature structured illumination microscope for in vivo 3D imaging of brain structures with optical sectioning

We present a high-resolution miniature, light-weight fluorescence microscope with electrowetting lens and onboard CMOS for high resolution volumetric imaging and structured illumination for rejection of out-of-focus and scattered light. The miniature microscope (SIMscope3D) delivers structured light using a coherent fiber bundle to obtain optical sectioning with an axial resolution of 18 &micro;m. Volumetric imaging of eGFP labeled cells in fixed mouse brain tissue at depths up to 260 &micro;m is demonstrated. The functionality of SIMscope3D to provide background free 3D imaging is shown by recording time series of microglia dynamics in awake mice at depths up to 120 &micro;m in the brain. &nbsp;</p

Imaging biomarker roadmap for cancer studies.

Imaging biomarkers (IBs) are integral to the routine management of patients with cancer. IBs used daily in oncology include clinical TNM stage, objective response and left ventricular ejection fraction. Other CT, MRI, PET and ultrasonography biomarkers are used extensively in cancer research and drug development. New IBs need to be established either as useful tools for testing research hypotheses in clinical trials and research studies, or as clinical decision-making tools for use in healthcare, by crossing 'translational gaps' through validation and qualification. Important differences exist between IBs and biospecimen-derived biomarkers and, therefore, the development of IBs requires a tailored 'roadmap'. Recognizing this need, Cancer Research UK (CRUK) and the European Organisation for Research and Treatment of Cancer (EORTC) assembled experts to review, debate and summarize the challenges of IB validation and qualification. This consensus group has produced 14 key recommendations for accelerating the clinical translation of IBs, which highlight the role of parallel (rather than sequential) tracks of technical (assay) validation, biological/clinical validation and assessment of cost-effectiveness; the need for IB standardization and accreditation systems; the need to continually revisit IB precision; an alternative framework for biological/clinical validation of IBs; and the essential requirements for multicentre studies to qualify IBs for clinical use.Development of this roadmap received support from Cancer Research UK and the Engineering and Physical Sciences Research Council (grant references A/15267, A/16463, A/16464, A/16465, A/16466 and A/18097), the EORTC Cancer Research Fund, and the Innovative Medicines Initiative Joint Undertaking (grant agreement number 115151), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations (EFPIA) companies' in kind contribution